日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-a]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity

设计、合成和分子建模吡唑并[1,5-a]嘧啶衍生物作为CDK2和TRKA激酶的双重抑制剂及其抗增殖活性

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph17121667
Attia, Mohamed H; Lasheen, Deena S; Samir, Nermin; Taher, Azza T; Abdel-Aziz, Hatem A; Abou El Ella, Dalal A
信号转导
CDK2
发表日期：2024
文献求助 收藏

Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors

新型吗啉嘧啶-5-腈衍生物作为双重PI3K/mTOR抑制剂的设计、合成和生物学评价

期刊:RSC Medicinal Chemistry
影响因子:3.6
doi:10.1039/d3md00693j
Rady, Ghada S; El Deeb, Moshira A; Sarg, Marwa T M; Taher, Azza T; Helwa, Amira A
mTOR
发表日期：2024
文献求助 收藏

New potential anti-SARS-CoV-2 and anti-cancer therapies of chitosan derivatives and its nanoparticles: Preparation and characterization

壳聚糖衍生物及其纳米粒子的新型潜在抗SARS-CoV-2和抗癌疗法：制备和表征

期刊:
影响因子:
doi:10.1016/j.arabjc.2023.104676
Ali, Mai; Mohamed, Mansoura I; Taher, Azza T; Mahmoud, Sara H; Mostafa, Ahmed; Sherbiny, Farag F; Kandile, Nadia G; Mohamed, Hemat M
SARS-CoV-2
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies

新型5-芳基-1,3,4-噻二唑类抗癌剂：设计、合成、体外生物学评价及体内放射性示踪研究

期刊:Pharmaceuticals
影响因子:
doi:10.3390/ph15121476
Rana M El-Masry, Basma M Essa, Adli A Selim, Soad Z El-Emam, Khaled O Mohamed, Tamer M Sakr, Hanan H Kadry, Azza T Taher, Sahar M Abou-Seri
肿瘤
发表日期：2022
文献求助 收藏